Shi, Yifeng
Olsson, Linnea T.
Hoadley, Katherine A. http://orcid.org/0000-0002-1216-477X
Calhoun, Benjamin C. http://orcid.org/0000-0001-6505-5430
Marron, J. S. http://orcid.org/0000-0003-2000-1476
Geradts, Joseph
Niethammer, Marc
Troester, Melissa A. http://orcid.org/0000-0001-9506-6624
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA016086, P50CA058223, U54CA156733)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Susan G. Komen (TREND21686258, SAC210102)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
National Science Foundation (DMS-2113404)
Article History
Received: 22 November 2022
Accepted: 20 October 2023
First Online: 11 November 2023
Competing interests
: The University of North Carolina, Chapel Hill has a license of intellectual property interest in GeneCentric Diagnostics and BioClassifier, LLC, which may be used in this study. The University of North Carolina, Chapel Hill may benefit from this interest that is/are related to this research. The terms of this arrangement have been reviewed and approved by the University of North Carolina, Chapel Hill Conflict of Interest Program in accordance with its conflict-of-interest policies. B.C.C. was a member of the Oncology Advisory Board for Luminex Corporation (9/2019-7/2022).